Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Follicular × obinutuzumab × Clear all

Phase

Status

Completed 19 Recruiting 13 Active not recruiting 9 Terminated 5 Not yet recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Indolent Non-Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 17 Rituximab 13 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 sargramostim 6 Vincristine 6 fludarabine phosphate 5 Radiotherapy 5 Doxorubicin 5 Cytarabine 5 Cisplatin 5 ibritumomab tiuxetan 4 Methylprednisolone 4 Melphalan 4 Etoposide 4 Dexamethasone 4 Cyclosporine 4 epratuzumab 3 Sensitivity and Specificity 3 Polymerase Chain Reaction 3 Mycophenolic Acid 3 Indium 3 Chlorambucil 3 Busulfan 3 Bendamustine Hydrochloride 3 Antilymphocyte Serum 3 Antigens, CD19 3 fludarabine 2 Radioimmunodetection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04934930 2021-06-22

FLMRD

Meir Medical Center

Phase 2 Unknown

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡